Recruiting
Procedure for Lung Cancer, sponsored by Middlemore Hospital, New Zealand
Get in touch This trial recruits from July 2015 for 152 weeks
Samantha Herath, MBBS, MPhil, FRACP
Phone: 0064-211298979
Email: samantha.herath@middlemore.co.nz
Eligibility Criteria
Age: From 18 Years To N/A
Gender: Both
Inclusion Criteria
All patients aged >18 years with a peripheral pulmonary lesion, suspected of lung cancer, requiring a biopsy
The lesion will be included irrespective of the relationship to the bronchus or ground glass appearance.
Exclusion Criteria
Patients with mediastinal adenopathy amenable to liner EBUS should have this procedure first and enrolled only if it fails to derive a diagnosis.
Endobronchial tumour on flexible bronchoscopy
Platelet count>150
International Normalised Ratio >=1.5
Haemoglobin>100
Neutrophils >1.0
Glomerular Filtration Rate>30
Liver Function Test< 2 times upper limit of normal
Unable to give consent/intellectually impaired
NCT02395939
Randomised Controlled Trial Comparing the Diagnostic Yield of Radial Endo-Bronchial Ultra-Sound (R-EBUS) Guided Cryo-biopsy Vs. CT-guided Transthoracic Biopsy in Patients With Parenchymal Lung Lesion, Suspected of Lung Cancer (CT-CROP)
Comparing Diagnostic Yield Between R-EBUS Guided Cryo Biopsy Vs. CT Guided Biopsy for PPL